INS and type 1 diabetes mellitus: Exogenous insulin administration to individuals with type 1 diabetes (T1D) is a life-saving therapy, but does not mimic the fine-tuned blood glucose control achieved by insulin secretion from endogenous pancreatic islet β cells1.